Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.

by Von Hoff, D. D., Goodwin, A. L., Garcia, L.
Published 1998

Human colon cancer cell lines secrete alpha TGF-like activity.

by Hanauske, A. R., Buchok, J., Scheithauer, W., Von Hoff, D. D.
Published 1987

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

by Ramanathan, R. K., Korn, R. L., Chiorean, E. G., Liu, H., Von Hoff, D. D.
Published 2016

A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice.

by Jackson, J. K., Min, W., Cruz, T. F., Cindric, S., Arsenault, L., Von Hoff, D. D., Degan, D., Hunter, W. L., Burt, H. M.
Published 1997

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic a...

by Ramanathan, R. K., Goldstein, D., Korn, R. L., Arena, F., Moore, M., Siena, S., Teixeira, L., Tabernero, J., Van Laethem, J.-L., Liu, H., McGovern, D., Lu, B., Von Hoff, D. D.
Published 2016

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients...

by Chiorean, E. G., Von Hoff, D. D., Reni, M., Arena, F. P., Infante, J. R., Bathini, V. G., Wood, T. E., Mainwaring, P. N., Muldoon, R. T., Clingan, P. R., Kunzmann, V., Ramanathan, R. K., Tabernero, J., Goldstein, D., McGovern, D., Lu, B., Ko, A.
Published 2016